Pravastatin
- Dosage form
- Tablet
- Available strengths
- 10 mg, 20 mg, 40 mg, 80 mg
- Drug class
- HMG-CoA reductase inhibitor (lipid metabolism regulator)
- Common brand
- Generic products
Clinical overview. Pravastatin is an HMG-CoA reductase inhibitor (statin) used with diet to lower LDL cholesterol and reduce cardiovascular risk. It is not significantly metabolized through the cytochrome P450 pathway, giving it the lowest drug-interaction potential among commonly used statins. It is taken once daily, usually at bedtime, and is contraindicated in pregnancy and breastfeeding.
Indication
Common therapeutic uses
- Used as an adjunct to diet to lower elevated total cholesterol, LDL-C, and apolipoprotein B, and to raise HDL-C, in primary hypercholesterolemia and mixed dyslipidemia.
- Used to reduce the risk of myocardial infarction, stroke, and cardiovascular death in patients with hypercholesterolemia or established coronary heart disease.
Pregnancy
Risk assessment and monitoring considerations
Contraindicated in pregnancy. Confirm pregnancy status and discuss alternative therapy with the prescriber before dispensing.
- Contraindicated in pregnancy: cholesterol and products of cholesterol synthesis are essential for normal fetal development, and pravastatin should be stopped immediately if a patient becomes pregnant while taking it.
- Should be used only in women of childbearing age who are highly unlikely to conceive and who have been informed of the potential risk to a fetus.
Breastfeeding
Infant exposure considerations
- Contraindicated in nursing women; pravastatin passes into human breast milk, and because of the potential for serious adverse effects in a nursing infant, women taking pravastatin should not breastfeed.
Geriatrics
Dosing and tolerability considerations
- Plasma concentrations are somewhat higher in older adults, but dose adjustment based on age alone is not routinely required; monitor for muscle-related adverse effects, which may be more common in this population.
Pediatrics
Use in children and adolescents
- May be used in children and adolescents 8 years of age and older with heterozygous familial hypercholesterolemia who have not responded adequately to diet alone.
- Not established in children under 8 years of age.
Dosage & Administration
Practical dosing and administration
- Usual adult dose is 10 to 80 mg PO once daily at bedtime, taken without regard to meals.
- Consider a lower starting dose in patients with significant renal or hepatic impairment.
- Titrate no more often than every 4 weeks based on lipid response.
Common side effects
Frequently reported tolerability concerns
- Increased creatine kinase (CK) may occur.
- Increased liver transaminases (usually reversible) may occur.
- Mild upper gastrointestinal disturbances may occur.
- Muscle aches or pain (myalgia) may occur.
- Sleep disturbances may occur.
- Headache may occur.
- Skin rash may occur.
Serious side effects
Findings that may require urgent assessment
Serious side effects require immediate discussion with the prescriber or emergency care.
- Rare myopathy or rhabdomyolysis may occur, with muscle pain, tenderness, or weakness alongside markedly elevated creatine kinase, which can progress to acute kidney injury.
- Peripheral neuropathy has been reported rarely.
- Serious liver injury may occur rarely.
- Severe hypersensitivity reactions may occur rarely, including angioedema and severe skin reactions.
- Erectile dysfunction has been reported.
- Seek immediate medical attention if unexplained muscle pain, tenderness, or weakness occurs, or if signs of liver injury (yellowing of the skin or eyes, dark urine, abdominal pain) develop.
Use with caution
Situations requiring closer assessment
- Use cautiously in patients with risk factors for myopathy, including renal or hepatic impairment, hypothyroidism, advanced age, or heavy alcohol use.
- Monitor more closely for adverse effects in patients with moderate to severe renal impairment (creatinine clearance under 60 mL/min).
Contraindications
Situations where therapy may be inappropriate
- Contraindicated in patients with known hypersensitivity to pravastatin or any ingredient in the formulation.
- Contraindicated in active liver disease or unexplained persistent elevation of liver transaminases.
- Contraindicated with high alcohol consumption.
- Contraindicated during pregnancy and breastfeeding.
Drug interactions
Clinically relevant combinations
- Pravastatin is not significantly metabolized through the cytochrome P450 pathway, giving it the lowest drug-interaction potential of the commonly used statins.
- Fibrates (particularly gemfibrozil) and niacin still increase the risk of myopathy when combined with pravastatin despite the low CYP-mediated interaction potential.
- Cyclosporine can substantially increase pravastatin exposure; use the lowest effective dose and monitor closely.
- Cholestyramine and other bile acid sequestrant resins can reduce pravastatin absorption if taken together; separate dosing by at least 1 hour before or 4 hours after the resin.
- Clarithromycin and erythromycin can modestly increase pravastatin levels, though the interaction is smaller than with the CYP3A4-metabolized statins.
Food interactions
Meal-related administration
- May be taken without regard to meals.
- Does not have the clinically significant grapefruit juice interaction seen with the CYP3A4-metabolized statins.
Time of administration
Practical scheduling
- Usually taken at bedtime, though the once-daily dose may be taken at any consistent time of day.
Storage
Product handling
- Store at controlled room temperature and keep out of reach and sight of children.
Patient take-away
Key counselling points for a quick closing summary
- Pravastatin is a statin used along with diet and lifestyle changes to lower cholesterol and reduce cardiovascular risk.
- Take once daily, usually at bedtime, with or without food.
- Common side effects include mild stomach upset, muscle aches, headache, and sleep disturbances.
- Contact your prescriber right away for unexplained muscle pain, tenderness, or weakness, or for yellowing of the skin or eyes or dark urine.
- Store at controlled room temperature, out of reach and sight of children.
References
Source material and product information
For professional reference. Confirm patient-specific decisions against the current approved product monograph and applicable clinical guidance.